Guardant Health
GH
#2664
Rank
โ‚น439.36 B
Marketcap
โ‚น3,560
Share price
-4.25%
Change (1 day)
127.11%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

P/S ratio for Guardant Health (GH)

P/S ratio as of March 2025 (TTM): 6.80

According to Guardant Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -36.0. At the end of 2024 the company had a P/S ratio of 5.09.

P/S ratio history for Guardant Health from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20245.09-12.59%
20235.82-6.07%
20226.20-77.22%
202127.2-39.44%
202044.931.28%
201934.2-3.75%
201835.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
12.6 85.61%๐Ÿ‡บ๐Ÿ‡ธ USA
2.23-67.17%๐Ÿ‡บ๐Ÿ‡ธ USA